Cannabicitran: Difference between revisions
CSV import |
No edit summary |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:Cannabicitran_structure.png|Structure of Cannabicitran | File:Cannabicitran_structure.png|Structure of Cannabicitran | ||
Latest revision as of 19:31, 16 March 2025
Cannabicitran (CBT) is a cannabinoid that is found in the Cannabis plant. It is one of the many phytocannabinoids that contribute to the plant's medicinal properties.
Chemistry[edit]
Cannabicitran is a homologue of cannabidiol (CBD), with the molecular formula C21H30O2. It is a non-psychoactive cannabinoid, meaning it does not produce the "high" associated with tetrahydrocannabinol (THC).
Pharmacology[edit]
The pharmacological effects of cannabicitran are not well-studied. However, like other cannabinoids, it is believed to interact with the endocannabinoid system in the human body. This system plays a role in a variety of physiological processes, including pain sensation, mood, and memory.
Medical uses[edit]
While the medical uses of cannabicitran are not yet fully understood, it is believed to have potential therapeutic benefits. These may include anti-inflammatory, analgesic, and anti-anxiety effects. More research is needed to fully understand the potential medical uses of this cannabinoid.
Legal status[edit]
The legal status of cannabicitran varies by country and in some cases, by state or province. In many places, it is regulated under the same laws as other cannabinoids.
